After helping President Trump get elected, Elon Musk was poised to dominate the country’s A.I. policies. Then Mr. Altman ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...

Vaishnaw outlined India’s AI-driven initiatives spanning healthcare, education, agriculture, weather forecasting, disaster ...

The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...